XML 23 R12.htm IDEA: XBRL DOCUMENT

6. SHARE-BASED COMPENSATION

12 Months Ended

Dec. 31, 2020

Share-based Payment Arrangement [Abstract]

NOTE 6: SHARE-BASED COMPENSATION

The following table summarizes the activity of our nonvested restricted shares for the years ended December 31, 2020 and 2019:

	Restricted Shares			Weighted- Average Grant-Date Fair Value
Nonvested at December 31, 2018		230		$	0.83
Granted		200			0.65
Vested		(170	)		0.78
Nonvested at December 31, 2019		260		$	0.72
Granted		–			–
Vested		(110	)		0.82
Cancellations & Forfeitures		(150	)		0.65
Nonvested at December 31, 2020		–		$	–

The following table summarizes the activity of our nonvested stock options for the years ended December 31, 2020 and 2019:

	Shares Underlying Options			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)
Outstanding at December 31, 2018		–		$	–		–
Granted		300			0.70
Vested		(75	)		0.75
Outstanding at December 31, 2019		225		$	0.68		4.7
Granted		200			0.47
Vested		(225	)		0.59
Outstanding at December 31, 2020		200		$	0.57		4.1
Exercisable at December 31, 2020		300		$	0.63		3.8

For the years ended December 31, 2020 and 2019, we recognized a total of $117 and $250, respectively, of share-based compensation expense related to restricted stock awards and stock options, which is included in selling, general and administrative expenses in the accompanying consolidated statements of operations. The unamortized estimated fair value of nonvested shares of restricted stock awards and stock options was $48 and $134 at December 31, 2020 and 2019, respectively. These costs are expected to be recognized as expense over a weighted-average period of 0.35 years.